Reverse Engineering Competitors’ R&D Pipelines: Ethical Insights for Biotech Firms
The boardroom was tense. The head of a biotech startup sat surrounded by her team, scrutinizing a recent patent application from a competitor. “They’re working on something big,” she said, her voice steady but urgent. “If we don’t figure out where they’re heading, we’ll be left behind.” In the fast-paced world of biotechnology, where innovation …
Reverse Engineering Competitors’ R&D Pipelines: Ethical Insights for Biotech Firms Read More »